XIAP and breast cancer: In N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) treated mice, up-regulated XIAP stabilized nucleolin mRNA via Erks, which further increased RhoGDIβ mRNA stability, BC invasion and lung metastasis [37].